Artículos por temáticas

Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease

Shen Y, Wu Q, Shi J, Zhou S.

Biomed Pharmacother. 2020 Dec;132:110928. doi: 10.1016/j.biopha.2020.110928. Epub 2020 Oct 28.

A Mobile App Specifically Designed to Facilitate Exercise in Parkinson Disease: Single-Cohort Pilot Study on Feasibility, Safety, and Signal of Efficacy

Landers MR, Ellis TD.

JMIR Mhealth Uhealth. 2020 Oct 5;8(10):e18985. doi: 10.2196/18985.

Variations in hospitalization rates across Parkinson's Foundation Centers of Excellence

Zeldenrust F, Lidstone S, Wu S, Okun MS, Cubillos F, Beck J, Davis T, Lyons K, Nelson E, Rafferty M, Schmidt P, Dai Y, Marras C.

Parkinsonism Relat Disord. 2020 Dec;81:123-128. doi: 10.1016/j.parkreldis.2020.09.006. Epub 2020 Oct 3.

Rare VPS35 A320V Variant in Taiwanese Parkinson's Disease Indicates Disrupted CI-MPR Sorting and Impaired Mitochondrial Morphology

Wu YR, Lin CH, Chao CY, Chang CW, Chen CM, Lee-Chen GJ.

Brain Sci. 2020 Oct 27;10(11):E783. doi: 10.3390/brainsci10110783.

Apathy in Parkinson disease: Why we should care

Friedman JH, Goetz CG.

Neurology. 2020 Nov 17;95(20):893-894. doi: 10.1212/WNL.0000000000010961. Epub 2020 Oct 1.

Transcription factor EB: an emerging drug target for neurodegenerative disorders

Song JX, Liu J, Jiang Y, Wang ZY, Li M.

Drug Discov Today. 2021 Jan;26(1):164-172. doi: 10.1016/j.drudis.2020.10.013. Epub 2020 Oct 22.

Emerging role of S100B protein implication in Parkinson's disease pathogenesis

Angelopoulou E, Paudel YN, Piperi C.

Cell Mol Life Sci. 2020 Oct 14. doi: 10.1007/s00018-020-03673-x. Online ahead of print.

Population pharmacokinetics of levodopa gel infusion in Parkinson's disease: effects of entacapone infusion and genetic polymorphism

Senek M, Nyholm D, Nielsen EI.

Sci Rep. 2020 Oct 22;10(1):18057. doi: 10.1038/s41598-020-75052-2.

Disease Progression in Patients with Parkin-Related Parkinson's Disease in a Longitudinal Cohort

Sun YM, Yu HL, Zhou XY, Xiong WX, Luo SS, Chen C, Liu FT, Zhao J, Tang YL, Liang XN, Yang YJ, Shen B, Shen Y, Yu WB, Ding ZT, An Y, Wu JJ, Wang J.

Mov Disord. 2021 Feb;36(2):442-448. doi: 10.1002/mds.28349. Epub 2020 Oct 27.

An Explainable Machine Learning Model for Early Detection of Parkinson's Disease using LIME on DaTSCAN Imagery

Magesh PR, Myloth RD, Tom RJ.

Comput Biol Med. 2020 Nov;126:104041. doi: 10.1016/j.compbiomed.2020.104041. Epub 2020 Oct 8.

Methanolic extracts of a selected Egyptian Vicia faba cultivar mitigate the oxidative/inflammatory burden and afford neuroprotection in a mouse model of Parkinson's disease

Abdel-Sattar E, Mahrous EA, Thabet MM, Elnaggar DMY, Youssef AM, Elhawary R, Zaitone SA, Celia Rodríguez-Pérez, Segura-Carretero A, Mekky RH.

Inflammopharmacology. 2020 Oct 28. doi: 10.1007/s10787-020-00768-6. Online ahead of print.

The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View

Vezzani B, Carinci M, Patergnani S, Pasquin MP, Guarino A, Aziz N, Pinton P, Simonato M, Giorgi C.

Biomolecules. 2020 Oct 13;10(10):1437. doi: 10.3390/biom10101437.

Unraveling Pathophysiological Mechanisms of Parkinson's Disease: Contribution of CSF Biomarkers

Farotti L, Paolini Paoletti F, Simoni S, Parnetti L.

Biomark Insights. 2020 Oct 12;15:1177271920964077. doi: 10.1177/1177271920964077. eCollection 2020.

The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes

Belvisi D, Fabbrini A, De Bartolo MI, Costanzo M, Manzo N, Fabbrini G, Defazio G, Conte A, Berardelli A.

Mov Disord. 2021 Feb;36(2):370-379. doi: 10.1002/mds.28321. Epub 2020 Oct 10.

Gait variability is linked to the atrophy of the Nucleus Basalis of Meynert and is resistant to STN DBS in Parkinson's disease

Wilkins KB, Parker JE, Bronte-Stewart HM.

Neurobiol Dis. 2020 Dec;146:105134. doi: 10.1016/j.nbd.2020.105134. Epub 2020 Oct 10.